The maker of a popular medicine for schizophrenia has notified doctors that it minimized potentially fatal safety risks and made misleading claims about the drug in promotional materials.

Janssen Pharmaceutic Products sent a two-page letter to the health care community this past week to clarify the risks of Risperdal, Carol Goodrich, a spokeswoman for the Johnson & Johnson subsidiary, said Saturday.

 


Comments


View Comments / Leave a Comment

This post currently has 0 comments.
You can read the comments or leave your own thoughts.


    Last reviewed: By John M. Grohol, Psy.D. on 27 Jul 2004
    Published on PsychCentral.com. All rights reserved.

APA Reference
Grohol, J. (2004). Drug Maker Acknowledges Misleading Claims. Psych Central. Retrieved on August 20, 2014, from http://psychcentral.com/blog/archives/2004/07/27/drug-maker-acknowledges-misleading-claims/

 

Recent Comments
  • Truth: To my lovely girls, Learn how to twerk…..and you will see :).
  • Jennie: I looked this up today after realizing that my marriage is going in the direction of divorce. Seems that I am...
  • Magicandmyth: My sister and I are both in our early 30s. Since our mid-teens my sister slowly started showing signs...
  • 1eyedgal: Great article! I have been seeing a therapist for 4 years now. Been in group therapy for children of...
  • Maddie: I agree that the title should read “6 drugs with the potential to cause weight gain” as you...
Subscribe to Our Weekly Newsletter


Find a Therapist
Enter ZIP or postal code



Users Online: 10275
Join Us Now!